SCHEMBL7307019

SCHEMBL7307019

CC(=O)c1cc([O])cc(C(C)=O)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA5A P35218 1/20 0.55
LMNA P02545 2/20 0.44
MAPT P10636 3/20 0.39
HPGD P15428 3/20 0.39
RAB9A P51151 2/20 0.39
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NPC1 O15118 1/20 0.38
HSD17B1 P14061 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP2A6 P11509 1/20 0.37
PKM P14618 1/20 0.35
MEN1 O00255 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAPK1 P28482 1/20 0.34
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
PRKCI P41743 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL669554 0.87 CA5A (0.67) CA5ALMNAMAPTHPGDRAB9A
SCHEMBL9350174 0.77 TPMT (0.55) CA5ALMNAMAPTHPGDSMN1; SMN2
SCHEMBL7307023 0.77 CA5A (0.89) CA5ALMNAHPGDKMT2AHSD17B1
SCHEMBL11762568 0.77 TPMT (0.55) CA5ALMNAMAPTHPGDSMN1; SMN2
SCHEMBL2624954 0.77 TPMT (0.55) CA5ALMNAMAPTHPGDRAB9A
SCHEMBL23469962 0.74 CA5A (0.52) CA5ALMNAMAPTHPGDRAB9A
SCHEMBL15709749 0.74 CA5A (0.52) CA5ALMNAMAPTHPGDRAB9A
SCHEMBL13307545 0.74 CA5A (0.52) CA5ALMNAMAPTHPGDRAB9A
SCHEMBL22198391 0.74 CA5A (0.52) CA5ALMNAMAPTHPGDRAB9A
SCHEMBL5090099 0.74 CA5A (0.52) CA5ALMNAMAPTL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed